Oncotarget is a weekly peer-reviewed medical journal covering research on diagnosis and treatment of cancer. Oncotarget was founded in 2010 by Dr. Mikhail Blagosklonny and is usually published by Impact Journals. In 2015, Oncotarget was recognized as the top publisher of research papers that covers oncological topics.
About Oncotarget and its achievements
Experienced scientists and team of veteran editors ensure only well-referenced materials are published via Oncotarget. Oncotarget mission is to:
• To make sure the public can easily access high-quality research works
• Eliminate border among specialties
• Maximize research outcome through insightful reviews and share research discoveries promptly
• Promote application of clinical and basic science in treatment of diseases
• Merge different specialties in biomedical science
Over the years, Oncotarget has expanded its coverage beyond oncology On msubmit.net. It has included specialties such as pathology, Aging, Chromosome, Immunology & Microbiology, and Autophagy & Cell Death. Other sections include Pharmacology, Metabolism, Endocrinology, and Neuroscience.
This journal also sponsors conferences on bioxbio.com. In August 2016, it sponsored the Rare Cells in Circulation Gordon Research Conference held at South Hadley. It also sponsored the Cell Fate Diversity in Aging Conference held in Croatia.
Oncotarget editorial board
The chief editors of the journal consist of Dr. Blagosklonny and Andrei Gudkov. The journal’s top editor, Dr. Blagosklonny, is an oncologist at the Roswell Park Cancer Institute, New York. He is also a researcher who pioneered in TOR Signaling in aging and cancer. Other members of the editorial team include Gregg Semenza and William Kaelin. These two editors won the 2016 Lasker Award for discovering an oxygen-sensing pathway.
Oncotarget editors are scholars and professors from globally recognized universities and research institutes. Oncotarget has published over 370 research papers on oxygen-related topics since 2010. Researcher Gregg Semenza has authored seven papers on oxygen-related topics and published them through Oncotarget. Under the guidance of internationally acclaimed researchers, the journal assists both young and veteran researchers in promoting the progress of science and discovery of treatment for diseases. The ultimate objective of the journal is to achieve a life free of diseases.
Oncotarget aging and age-related disease division
This section publishes papers on age-related research on ncbi.nlm.nih.gov including mechanisms and evolution of aging, cellular senescence, longevity from yeast to humans, and signal transduction pathways. This division has an advisory board that assists in running the journal’s activities. Its advisory board is comprised of scientists in the field of gerotarget.